Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies

J. L. Brozek, E. A. Akl, R. Jaeschke, D. M. Lang, P. Bossuyt, P. Glasziou, M. Helfand, E. Ueffing, P. Alonso-Coello, J. Meerpohl, B. Phillips, A. R. Horvath, J. Bousquet, G. H. Guyatt, H. J. Schünemann

Research output: Contribution to journalReview articleResearchpeer-review

113 Citations (Scopus)

Abstract

The GRADE approach to grading the quality of evidence and strength of recommendations provides a comprehensive and transparent approach for developing clinical recommendations about using diagnostic tests or diagnostic strategies. Although grading the quality of evidence and strength of recommendations about using tests shares the logic of grading recommendations for treatment, it presents unique challenges. Guideline panels and clinicians should be alert to these special challenges when using the evidence about the accuracy of tests as the basis for clinical decisions. In the GRADE system, valid diagnostic accuracy studies can provide high quality evidence of test accuracy. However, such studies often provide only low quality evidence for the development of recommendations about diagnostic testing, as test accuracy is a surrogate for patient-important outcomes at best. Inferring from data on accuracy that using a test improves outcomes that are important to patients requires availability of an effective treatment, improved patients' wellbeing through prognostic information, or - by excluding an ominous diagnosis - reduction of anxiety and the opportunity for earlier search for an alternative diagnosis for which beneficial treatment can be available. Assessing the directness of evidence supporting the use of a diagnostic test requires judgments about the relationship between test results and patient-important consequences. Well-designed and conducted studies of allergy tests in parallel with efforts to evaluate allergy treatments critically will encourage improved guideline development for allergic diseases.

Original languageEnglish
Pages (from-to)1109-1116
Number of pages8
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume64
Issue number8
DOIs
Publication statusPublished - Aug 2009
Externally publishedYes

Fingerprint

Practice Guidelines
Routine Diagnostic Tests
Hypersensitivity
Guidelines
Therapeutics
Anxiety

Cite this

Brozek, J. L. ; Akl, E. A. ; Jaeschke, R. ; Lang, D. M. ; Bossuyt, P. ; Glasziou, P. ; Helfand, M. ; Ueffing, E. ; Alonso-Coello, P. ; Meerpohl, J. ; Phillips, B. ; Horvath, A. R. ; Bousquet, J. ; Guyatt, G. H. ; Schünemann, H. J. / Grading quality of evidence and strength of recommendations in clinical practice guidelines : Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies. In: Allergy: European Journal of Allergy and Clinical Immunology. 2009 ; Vol. 64, No. 8. pp. 1109-1116.
@article{bc767307dc554ebda1939fabe8ff3484,
title = "Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies",
abstract = "The GRADE approach to grading the quality of evidence and strength of recommendations provides a comprehensive and transparent approach for developing clinical recommendations about using diagnostic tests or diagnostic strategies. Although grading the quality of evidence and strength of recommendations about using tests shares the logic of grading recommendations for treatment, it presents unique challenges. Guideline panels and clinicians should be alert to these special challenges when using the evidence about the accuracy of tests as the basis for clinical decisions. In the GRADE system, valid diagnostic accuracy studies can provide high quality evidence of test accuracy. However, such studies often provide only low quality evidence for the development of recommendations about diagnostic testing, as test accuracy is a surrogate for patient-important outcomes at best. Inferring from data on accuracy that using a test improves outcomes that are important to patients requires availability of an effective treatment, improved patients' wellbeing through prognostic information, or - by excluding an ominous diagnosis - reduction of anxiety and the opportunity for earlier search for an alternative diagnosis for which beneficial treatment can be available. Assessing the directness of evidence supporting the use of a diagnostic test requires judgments about the relationship between test results and patient-important consequences. Well-designed and conducted studies of allergy tests in parallel with efforts to evaluate allergy treatments critically will encourage improved guideline development for allergic diseases.",
author = "Brozek, {J. L.} and Akl, {E. A.} and R. Jaeschke and Lang, {D. M.} and P. Bossuyt and P. Glasziou and M. Helfand and E. Ueffing and P. Alonso-Coello and J. Meerpohl and B. Phillips and Horvath, {A. R.} and J. Bousquet and Guyatt, {G. H.} and Sch{\"u}nemann, {H. J.}",
year = "2009",
month = "8",
doi = "10.1111/j.1398-9995.2009.02083.x",
language = "English",
volume = "64",
pages = "1109--1116",
journal = "Allergy: European Journal of Allergy and Clinical Immunology",
issn = "0105-4538",
publisher = "Wiley-Blackwell",
number = "8",

}

Brozek, JL, Akl, EA, Jaeschke, R, Lang, DM, Bossuyt, P, Glasziou, P, Helfand, M, Ueffing, E, Alonso-Coello, P, Meerpohl, J, Phillips, B, Horvath, AR, Bousquet, J, Guyatt, GH & Schünemann, HJ 2009, 'Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies' Allergy: European Journal of Allergy and Clinical Immunology, vol. 64, no. 8, pp. 1109-1116. https://doi.org/10.1111/j.1398-9995.2009.02083.x

Grading quality of evidence and strength of recommendations in clinical practice guidelines : Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies. / Brozek, J. L.; Akl, E. A.; Jaeschke, R.; Lang, D. M.; Bossuyt, P.; Glasziou, P.; Helfand, M.; Ueffing, E.; Alonso-Coello, P.; Meerpohl, J.; Phillips, B.; Horvath, A. R.; Bousquet, J.; Guyatt, G. H.; Schünemann, H. J.

In: Allergy: European Journal of Allergy and Clinical Immunology, Vol. 64, No. 8, 08.2009, p. 1109-1116.

Research output: Contribution to journalReview articleResearchpeer-review

TY - JOUR

T1 - Grading quality of evidence and strength of recommendations in clinical practice guidelines

T2 - Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies

AU - Brozek, J. L.

AU - Akl, E. A.

AU - Jaeschke, R.

AU - Lang, D. M.

AU - Bossuyt, P.

AU - Glasziou, P.

AU - Helfand, M.

AU - Ueffing, E.

AU - Alonso-Coello, P.

AU - Meerpohl, J.

AU - Phillips, B.

AU - Horvath, A. R.

AU - Bousquet, J.

AU - Guyatt, G. H.

AU - Schünemann, H. J.

PY - 2009/8

Y1 - 2009/8

N2 - The GRADE approach to grading the quality of evidence and strength of recommendations provides a comprehensive and transparent approach for developing clinical recommendations about using diagnostic tests or diagnostic strategies. Although grading the quality of evidence and strength of recommendations about using tests shares the logic of grading recommendations for treatment, it presents unique challenges. Guideline panels and clinicians should be alert to these special challenges when using the evidence about the accuracy of tests as the basis for clinical decisions. In the GRADE system, valid diagnostic accuracy studies can provide high quality evidence of test accuracy. However, such studies often provide only low quality evidence for the development of recommendations about diagnostic testing, as test accuracy is a surrogate for patient-important outcomes at best. Inferring from data on accuracy that using a test improves outcomes that are important to patients requires availability of an effective treatment, improved patients' wellbeing through prognostic information, or - by excluding an ominous diagnosis - reduction of anxiety and the opportunity for earlier search for an alternative diagnosis for which beneficial treatment can be available. Assessing the directness of evidence supporting the use of a diagnostic test requires judgments about the relationship between test results and patient-important consequences. Well-designed and conducted studies of allergy tests in parallel with efforts to evaluate allergy treatments critically will encourage improved guideline development for allergic diseases.

AB - The GRADE approach to grading the quality of evidence and strength of recommendations provides a comprehensive and transparent approach for developing clinical recommendations about using diagnostic tests or diagnostic strategies. Although grading the quality of evidence and strength of recommendations about using tests shares the logic of grading recommendations for treatment, it presents unique challenges. Guideline panels and clinicians should be alert to these special challenges when using the evidence about the accuracy of tests as the basis for clinical decisions. In the GRADE system, valid diagnostic accuracy studies can provide high quality evidence of test accuracy. However, such studies often provide only low quality evidence for the development of recommendations about diagnostic testing, as test accuracy is a surrogate for patient-important outcomes at best. Inferring from data on accuracy that using a test improves outcomes that are important to patients requires availability of an effective treatment, improved patients' wellbeing through prognostic information, or - by excluding an ominous diagnosis - reduction of anxiety and the opportunity for earlier search for an alternative diagnosis for which beneficial treatment can be available. Assessing the directness of evidence supporting the use of a diagnostic test requires judgments about the relationship between test results and patient-important consequences. Well-designed and conducted studies of allergy tests in parallel with efforts to evaluate allergy treatments critically will encourage improved guideline development for allergic diseases.

UR - http://www.scopus.com/inward/record.url?scp=67650280868&partnerID=8YFLogxK

U2 - 10.1111/j.1398-9995.2009.02083.x

DO - 10.1111/j.1398-9995.2009.02083.x

M3 - Review article

VL - 64

SP - 1109

EP - 1116

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

SN - 0105-4538

IS - 8

ER -